The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
Open accessAbstract
Significance Enzymes of the folate cycle are among the most consistently overexpressed proteins in cancer. Whereas multiple clinical agents inhibit thymidylate synthase, no current drugs target the incorporation of one-carbon into folates via serine hydroxymethyltransferase (SHMT). Using genetics, we show that cancer cells require SHMT to generate tumors. We then describe small-molecule SHMT inhibitors, and show that they block the growth of many human cancer cells, with B-cell lymphomas particularly sensitive to SHMT inhibition. We find that this sensitivity arises from the lymphomas’ inability to import the amino acid glycine, which is made as a byproduct of the SHMT reaction. Thus, B-cell lymphomas have an intrinsic defect in amino acid import, which causes a therapeutically targetable metabolic vulnerability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further optimization of this scaffold led to potent inhibitors of both SHMT1 and SHMT2.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [143]
In the citing paper
“Prior to Nonaka and co-worker’s study, generally, only marginal selectivity between the two SHMT isoforms has been achieved, with the inhibitors being selective for SHMT1 by 2- to 3-fold.”
From A review of small-molecule inhibitors of one-carbon enzymes: SHMT2 and MTHFD2 in the spotlight (2021) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 1×
“C growth and proliferation are supported by metabolic changes, including enhanced glucose uptake, aerobic glycolysis (the Warburg effect), and folate-dependent one-carbon (1C) metabolism (1, 2).”
BackgroundDouble nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
One-Carbon Metabolism in Health and Disease
Ducker, G. S., & Rabinowitz, J. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.009 · Cited by 2,239
Treatment of Acute Lymphoblastic Leukemia
Pui, C., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 2,012
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 945
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Cited by
Sorted by citations
Items 101–200 of 263
Extracellular serine empowers epidermal proliferation and psoriasis-like symptoms
Cappello, A., Mancini, M., Madonna, S., Rinaldo, S., Paone, A., Scarponi, C., Belardo, A., Zolla, L., Zuccotti, A., Panatta, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm7902 · Cited by 30
Schwertz, G., Witschel, M. C., Rottmann, M., Leartsakulpanich, U., Chitnumsub, P., Jaruwat, A., Amornwatcharapong, W., Ittarat, W., Schäfer, A., Aponte, R. A., et al. (2018) · ChemMedChem · doi:10.1002/cmdc.201800053 · Cited by 27
Batool, N., Ko, K. S., Chaurasia, A. K., & Kim, K. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239135 · Cited by 24
Zarou, M. M., Rattigan, K. M., Sarnello, D., Shokry, E., Dawson, A., Ianniciello, A., Dunn, K. M., Copland, M., Sumpton, D. P., Vázquez, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46114-0 · Cited by 28
Metabolic adaptations of brain metastasis
Parida, P. K., & Malladi, S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00848-1 · Cited by 28
Shi, H., Fang, X., Li, Y., & Zhang, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.917435 · Cited by 25
Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
Wallace-Povirk, A., Hou, Z., Nayeen, M. J., Gangjee, A., & Matherly, L. H. (2021) · Cancers · doi:10.3390/cancers14010191 · Cited by 26
Cancer proteome and metabolite changes linked to SHMT2
Tong, J., Krieger, J. R., Taylor, P., Bagshaw, R., Kang, J., Jeedigunta, S., Wybenga-Groot, L. E., Zhang, W., Badr, H., Mirhadi, S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237981 · Cited by 24
“Towards understanding mechanisms of SHMT2 effects on cell proliferation and tumor growth, we sought to identify proteins associated with or proximal to SHMT2 by using proximity biotinylation (BioID) methodology [19].”
Nguyen, T., Vemu, P. L., Hoy, G. E., Boudjadi, S., Chatterjee, B., Shern, J. F., Khan, J. I., Sun, W., & Barr, F. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138022 · Cited by 24
Dietary Manipulation of Amino Acids for Cancer Therapy
Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 26
Korasick, D. A., Kandoth, P. K., Tanner, J. J., Mitchum, M. G., & Beamer, L. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012256 · Cited by 24
Chinopoulos, C. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.543564 · Cited by 23
Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer
Tarragó‐Celada, J., Foguet, C., Tarrado‐Castellarnau, M., Marín, S., Hernandez‐Alias, X., Perarnau, J., Morrish, F. M., Hockenbery, D. M., Gomis, R. R., Ruppin, E., et al. (2021) · Cancers · doi:10.3390/cancers13030425 · Cited by 23
One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review
Ghannad‐Zadeh, K., & Das, S. (2021) · Cancers · doi:10.3390/cancers13123067 · Cited by 23
One-Carbon and Polyamine Metabolism as Cancer Therapy Targets
Islam, A., Shaukat, Z., Hussain, R., & Gregory, S. L. (2022) · Biomolecules · doi:10.3390/biom12121902 · Cited by 22
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Pang, Y., Lu, T., Xu-Monette, Z. Y., & Young, K. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065493 · Cited by 28
Metabolomics Reveals Metabolic Changes Caused by Low-Dose 4-Tert-Octylphenol in Mice Liver
Zhou, K., Ding, X., Yang, J., Hu, Y., Song, Y., Chen, M., Sun, R., Dong, T., Xu, B., Han, X., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15122686 · Cited by 22
Inferring cancer dependencies on metabolic genes from large-scale genetic screens
Lagziel, S., Lee, W. D., & Shlomi, T. (2019) · BMC Biology · doi:10.1186/s12915-019-0654-4 · Cited by 21
Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin’s Lymphoma
Alfaifi, A., Refai, M. Y., Alsaadi, M., Bahashwan, S., Malhan, H. M., Al-Kahiry, W., Dammag, E. A. M., Ageel, A., Mahzary, A., Albiheyri, R. S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13050861 · Cited by 21
The role of dNTP metabolites in control of the embryonic cell cycle
Liu, B., & Großhans, J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1665948 · Cited by 21
Analysing central metabolism in ultra-high resolution: At the crossroads of carbon and nitrogen
Bayram, Ş., Fürst, S., Forbes, M., & Kempa, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.002 · Cited by 21
Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer
Wang, H., Chong, T., Li, B.-Y., Chen, X.-S., & Zhen, W.-B. (2020) · Biological Research · doi:10.1186/s40659-020-00314-2 · Cited by 20
CMSSP: A Contrastive Mass Spectra-Structure Pretraining Model for Metabolite Identification
Chen, L., Xia, B., Wang, Y., Huang, X., Gu, Y., Wu, W., & Zhou, Y. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03724 · Cited by 19
Monti, M. M., Guiducci, G., Paone, A., Rinaldo, S., Giardina, G., Liberati, F. R., Cutruzzolà, F., & Tartaglia, G. G. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.019 · Cited by 20
Glenny, E. M., Coleman, M. F., Giles, E. D., Wellberg, E. A., & Hursting, S. D. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-032437 · Cited by 18
Tramonti, A., Paiardini, A., Paone, A., Bouzidi, A., Giardina, G., Guiducci, G., Magnifico, M. C., Rinaldo, S., McDermott, L., Menendez, J. A., et al. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.07.001 · Cited by 18
Biocatalytic One-Carbon Transfer – A Review
Müller, M., Germer, P., & Andexer, J. N. (2022) · Synthesis · doi:10.1055/s-0040-1719884 · Cited by 17
A Transfer Hydrogenation Approach to Activity-Based Sensing of Formate in Living Cells
Crossley, S. W. M., Tenney, L., Pham, V. N., Xie, X., Zhao, M., & Chang, C. J. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09735 · Cited by 17
SHMT2 Induces Stemness and Progression of Head and Neck Cancer
Jin, Y., Jung, S., Lim, M. A., Oh, C., Piao, Y., Kim, H. J., Nguyena, Q., Kang, Y. E., Chang, J. W., Won, H.-R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179714 · Cited by 18
Nayeen, M. J., Katinas, J. M., Magdum, T., Shah, K., Wong-Roushar, J., O’Connor, C. E., Fifer, A. N., Wallace-Povirk, A., Hou, Z., Matherly, L. H., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00763 · Cited by 17
Folate depletion induces erythroid differentiation through perturbation of de novo purine synthesis
Maynard, A. G., Pohl, N. K., Mueller, A., Petrova, B., Wong, A. Y. L., Wang, P., Culhane, A. J., Brook, J. R., Hirsch, L. M., Hoang, N., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj9479 · Cited by 17
Sánchez‐Castillo, A., & Kampen, K. R. (2024) · Discover Oncology · doi:10.1007/s12672-024-01544-6 · Cited by 18
Theoretical Evaluation of the Reaction Mechanism of Serine Hydroxymethyltransferase
Santatiwongchai, J., Gleeson, D., & Gleeson, M. P. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b10196 · Cited by 17
Fux, A., Pfanzelt, M., Kirsch, V. C., Hoegl, A., & Sieber, S. A. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.08.003 · Cited by 17
Ubonprasert, S., Jaroensuk, J., Pornthanakasem, W., Kamonsutthipaijit, N., Wongpituk, P., Mee-udorn, P., Rungrotmongkol, T., Ketchart, O., Chitnumsub, P., Leartsakulpanich, U., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007454 · Cited by 17
Jiang, Y., Qing, T., Qiao, X., Yang, Y., Chen, P., Han, M., Dong, K., Zhang, W., Xu, M., Wang, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508730 · Cited by 18
One-carbon metabolism in cancer: moonlighting functions of metabolic enzymes and anti-tumor therapy
Cao, X., Guo, Y., Guo, Z., Liu, Y., Dou, Y., & Xue, L. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10308-9 · Cited by 18
Amino acids metabolism: a potential target for cancer treatment
Ren, S., Zhou, X., Wang, Z., & Yuan, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02523-3 · Cited by 19
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells
Wang, K., Lu, Y., Li, H., Zhang, J., Ju, Y., & Ouyang, M. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03194-0 · Cited by 16
1-C Metabolism—Serine, Glycine, Folates—In Acute Myeloid Leukemia
Mahmood, K., & Emadi, A. (2021) · Pharmaceuticals · doi:10.3390/ph14030190 · Cited by 16
A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production
Wit, N., Gogola, E., West, J. A., Vornbäumen, T., Seear, R., Bailey, P. S. J., Burgos-Barragan, G., Wang, M., Krawczyk, P. A., Huberts, D. H. E. W., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2235 · Cited by 18
Cytosolic localization and in vitro assembly of human de novo thymidylate synthesis complex
Spizzichino, S., Boi, D., Boumis, G., Lucchi, R., Liberati, F. R., Capelli, D., Montanari, R., Pochetti, G., Piacentini, R., Parisi, G., et al. (2021) · FEBS Journal · doi:10.1111/febs.16248 · Cited by 15
Advances in Understanding of Metabolism of B-Cell Lymphoma: Implications for Therapy
Kľučková, K., D’Avola, A., & Riches, J. C. (2022) · Cancers · doi:10.3390/cancers14225552 · Cited by 16
Sugarman, A. J., Huynh, L. D., Shabro, A., & Cristofano, A. D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216304 · Cited by 15
Wallace-Povirk, A., O’Connor, C. E., Dekhne, A. S., Bao, X., Nayeen, M. J., Schneider, M. J., Katinas, J. M., Wong-Roushar, J., Kim, S., Polin, L., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0550 · Cited by 15
Phosphorylated SHMT2 Regulates Oncogenesis Through m6A Modification in Lung Adenocarcinoma
Han, T., Wang, Y., Cheng, M., Hu, Q., Wan, X., Huang, M.-L., Liu, Y., Xun, W., Xu, J., Wang, L., et al. (2024) · Advanced Science · doi:10.1002/advs.202307834 · Cited by 17
Microprotein SMIM26 drives oxidative metabolism via serine-responsive mitochondrial translation
Nah, J. M., Mahendran, S., Kerouanton, B., Liang, C., Hock, D. H., Cabrera‐Orefice, A., Dunlap, K., Robinson, D. R. L., Tung, D. W. H., Leong, S. H., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.05.033 · Cited by 17
DNA polymerase theta protects leukemia cells from metabolic-induced DNA damage
Vekariya, U. M., Toma, M. M., Nieborowska-Skorska, M., Le, B. V., Caron, M., Kukuyan, A.-M., Sullivan-Reed, K., Podszywalow‐Bartnicka, P., Chitrala, K. N., Atkins, J., et al. (2022) · Blood · doi:10.1182/blood.2022018428 · Cited by 14
Sato, Y., Matsuda, S., Maruyama, A., Nakayama, J., Miyashita, T., Udagawa, H., Umemura, S., Yanagihara, K., Ochiai, A., Tomita, M., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01129 · Cited by 15
Deng, H., Wang, Y., Xiao, L., Feng, M., Dou, W., & Pan, Y. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00926-5 · Cited by 13
Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy
Zhang, X., & Wang, Z. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1335785 · Cited by 13
O’Connor, C. E., Schneider, M. J., Katinas, J. M., Nayeen, M. J., Shah, K., Magdum, T., Sharma, A., Kim, S., Bao, X., Li, J., et al. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000912 · Cited by 13
You, H., Havey, L., Li, Z., Wang, Y., Asara, J. M., & Guo, R. (2025) · Science Advances · doi:10.1126/sciadv.adr8837 · Cited by 16
Identification of three new compounds that directly target human serine hydroxymethyltransferase 2
Han, Y., He, L., Qi, Y., Zhao, Y., Pan, Y., Fang, B., Li, S., Zhang, J. Z. H., & Zhang, L. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13774 · Cited by 13
Malatesta, M., Fornasier, E., di Salvo, M. L., Tramonti, A., Zangelmi, E., Peracchi, A., Secchi, A., Polverini, E., Giachin, G., Battistutta, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47466-3 · Cited by 13
Jiménez‐Alonso, J. J., Guillén-Mancina, E., Calderón‐Montaño, J. M., Jiménez-González, V., Díaz-Ortega, P., Burgos‐Morón, E., & López‐Lázaro, M. (2022) · Nutrients · doi:10.3390/nu14163378 · Cited by 12
Drago, V. N., Campos, C., Hooper, M., Collins, A. J., Gerlits, O. O., Weiss, K. L., Blakeley, M. P., Phillips, R. S., & Kovalevsky, A. Y. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00964-9 · Cited by 11
Role of ubiquitination-driven metabolisms in oncogenesis and cancer therapy
Yang, D., Yang, C., Huang, L., Guan, M. Y., & Song, C. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.004 · Cited by 12
Tait-Mulder, J., Hodge, K., Sumpton, D. P., Zanivan, S. R., & Vázquez, A. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00228-3 · Cited by 11
Ren, Y., Fan, L., Wang, L., Liu, Y., Zhang, J., Wang, B., Chen, R., Chen, X., Zhuang, L., Zhang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202415698 · Cited by 10
Glycine metabolomic changes induced by anticancer agents in A549 cells
Guo, K., Cao, Y., Li, Z., Zhou, X., Ding, R., Chen, K., Liu, Y., Qiu, Y., Wu, Z., & Fang, M. (2020) · Amino Acids · doi:10.1007/s00726-020-02853-0 · Cited by 13
Li, X., Peng, L., Yang, X., Luo, J., Wang, J., Mou, K., Zhou, H., Luo, Y., & Li, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1464042 · Cited by 9
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer
Cappello, A., Tosetti, G., Smirnov, A., Ganini, C., Yang, X. F., Shi, Y., Wang, Y., Melino, G., Bernassola, F., & Candi, E. (2023) · Biology Direct · doi:10.1186/s13062-023-00426-1 · Cited by 9
Jiao, Z., Zhang, M., Ning, J., Yao, H., Yan, X., Wu, Z., Wu, D., Liu, Y., Zhang, M., Wang, L., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412854122 · Cited by 8
Metabolic Targets in CRC: The Emerging Role of Cytochrome P450 Inhibitors
Alshakarchi, H. I., Azari, H., Jeddoa, Z. M. A., Jafar, N. N. A., Khazaei, Y., Gataa, I. S., Ferns, G. A., & Avan, A. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128341167250520063502 · Cited by 8
Aspartate availability drives differential engagement of the malate-aspartate shuttle
Brunner, J. S., Bridgeman, A. E., Jackson, B. T., Chakraborty, S., Fagoaga-Eugui, M., Paras, K. I., Xie, A., Arnold, P. K., Losner, J., & Finley, L. W. S. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.02.004 · Cited by 8
Serine-associated one-carbon metabolic reprogramming: a new anti-cancer therapeutic strategy
Zhang, J., Bai, J., Chen, G., Wang, J., Cheng, Y., Zhao, J., & Xiong, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1184626 · Cited by 8
Korasick, D. A., Owuocha, L. F., Kandoth, P. K., Tanner, J. J., Mitchum, M. G., & Beamer, L. J. (2023) · FEBS Journal · doi:10.1111/febs.16971 · Cited by 8
Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and LymphomaPreprint
Stahl, M. F., Epstein-Peterson, Z. D., & Intlekofer, A. M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035477 · Cited by 8
Ghrayeb, A., Agranovich, B., Peled, D., Finney, A. C., Abramovich, I., Fernández-García, J., Traylor, J. G., Drucker, S., Fernandes, S. I., Weissman, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.16.524043 · Cited by 8
Glycolytic metabolism and biomass production from glucose in human skeletal muscle growth
Mäntyselkä, S., Ahvenlammi, M., Vartiainen, J., Halonen, E. J., Kolari, K., Wackerhage, H., Permi, P., Varjosalo, M. T., Kelahaara, M., Ahtiainen, J. P., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00525.2025 · Cited by 7
Vít, O., Talacko, P., Musil, Z., Hartmann, I., Pacák, K., & Petrák, J. (2023) · Clinical Proteomics · doi:10.1186/s12014-023-09428-7 · Cited by 7
Zheng, M., Zhou, X., Wang, Q., Chen, X., Cao, B., & Li, J. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1881513 · Cited by 8
Pu, Q., Ren, H., Ou, Q., Yang, X., Wei, T., Zhao, L., Han, Y., Lou, Y., Kashyap, S., & Liu, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143243 · Cited by 6
Zhu, S., Liu, Y., Chen, H., Zhu, X., Liu, X., Xu, K., Sang, Y., Shang, L., Chong, W., & Li, L. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251331755 · Cited by 6
Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma
Akram, H., Liu, Y., Dong, J., Zhao, X., Wang, L., Zhao, W., Liu, H., Ma, L., & Han, C. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109028 · Cited by 6
Schmidt, A., Pfeiffer, M., & Sdelci, S. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00097-8 · Cited by 7
Minchenko, О. H., Sliusar, M. Y., Khita, O. O., Viletska, Y. M., Luzina, O. Y., Danilovskyi, S. V., & Minchenko, D. O. (2024) · Endocrine Regulations · doi:10.2478/enr-2024-0016 · Cited by 6
Deuterium MRI of serine metabolism in mouse models of glioblastoma
Hesse, F., Low, J. C. M., Cao, J., Bulat, F., Kreis, F., Wright, A. J., & Brindle, K. M. (2024) · Magnetic Resonance in Medicine · doi:10.1002/mrm.30198 · Cited by 6
Ota, T., Senoo, A., Shirakawa, M., Nonaka, H., Saito, Y., Itô, S., Ueno, G., Nagatoishi, S., Tsumoto, K., & Sando, S. (2021) · iScience · doi:10.1016/j.isci.2021.102036 · Cited by 6
Katinas, J. M., Nayeen, M. J., Schneider, M. J., Shah, K., Fifer, A. N., Klapper, L. M., Sharma, A., Thalluri, K., VanNieuwenhze, M. S., Hou, Z., et al. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00613 · Cited by 6
Shi, M., Huai, Y., Deng, T., Zhang, C., Song, J., Wang, J., Zhang, Y., Chen, Z., Zhao, H., Wu, K., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102499 · Cited by 5
RNA-mediated inhibition of mitochondrial SHMT2 impairs cancer cell proliferation
Liberati, F., Spizzichino, S., Russo, S. D., Borsatti, G. E., Riva, A., Magnifico, M., Bouzidi, A., Giardina, G., Arese, M., Rossi, C. S., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02646-y · Cited by 4
Inhibition of SHMT2 mRNA translation increases embryonic mortality in sheep
Sah, N., Stenhouse, C., Halloran, K. M., Moses, R. M., Seo, H., Burghardt, R. C., Johnson, G. A., Wu, G., & Bazer, F. W. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac152 · Cited by 6
Targeting Metabolic Vulnerabilities in Epstein–Barr Virus-Driven Proliferative Diseases
Leung, N. Y. T., & Wang, L. W. (2023) · Cancers · doi:10.3390/cancers15133412 · Cited by 5
The association between serine hydroxymethyl transferase 1 gene hypermethylation and ischemic stroke
Wang, J., Gu, J., Huang, Y., Fang, Y., & Lin, J. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5188 · Cited by 5
Kringel, D., Malkusch, S., Kalso, E. A., & Lötsch, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020878 · Cited by 5
Effects of insufficient serine on health and selenoprotein expression in rats and their offspring
Liu, Y., Wang, J., Wang, Q., Han, F., Shi, L., Han, C., Huang, Z., & Xu, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1012362 · Cited by 5
Mee-udorn, P., Nutho, B., Chootrakool, R., Maenpuen, S., Leartsakulpanich, U., Chitnumsub, P., & Rungrotmongkol, T. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.119737 · Cited by 5
Zirpoli, S., Copperman, N., Patel, S., Forrest, A., Hou, Z., Matherly, L. H., Loeb, D. M., & Cristofano, A. D. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0218 · Cited by 4
Targeting Tumor Metabolism to Overcome Radioresistance
Wahl, D. R., Petronek, M. S., Rashmi, R., Floberg, J. M., Allen, B. G., & Schwarz, J. K. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_10 · Cited by 4
Vastrad, B. M., Pattanashetti, S., & Vastrad, C. M. (2025) · Research Square · doi:10.21203/rs.3.rs-7522725/v1 · Cited by 4
Pyko, J., Glaß, M., Rosemann, J., Kappler, M., Macho, J., Qasem, S. A., Hüttelmaier, S., Eckert, A. W., Hämmerle, M., & Gutschner, T. (2025) · 癌症：英文版 · doi:10.1002/cac2.12660 · Cited by 3
Synthesis and biological evaluation of innovative thiourea derivatives as PHGDH inhibitors
Xiang, J., Tao, L., Zhou, Y., Tan, Y., Li, Z., Zhao, Y., Sun, Q., & Luo, Y. (2020) · Chemical Papers · doi:10.1007/s11696-020-01188-0 · Cited by 3
Samarakoon, V., Owuocha, L. F., Hammond, J., Mitchum, M. G., & Beamer, L. J. (2024) · Biochemical Journal · doi:10.1042/bcj20240338 · Cited by 3
Jia, M., Lin, L., Yu, H., Dong, Z., Pan, X., & Song, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-85900-8 · Cited by 3
Screening and Analysis of Potential Inhibitors of SHMT2
Chen, B., & Zhang, J. Z. H. (2023) · Biophysica · doi:10.3390/biophysica3040044 · Cited by 2
Schneider, M. J., O’Connor, C. E., Bao, X., Nayeen, M. J., Magdum, T., Sharma, A., Li, J., Kim, S., Dann, C. E., Gangjee, A., et al. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100120 · Cited by 2
The application prospects of amino acid deprivation for cancer therapy
Meng, W., Wang, R., Peng, J., Li, Z., Ali, A. R., Bian, J., Huang, H., & Tian, Y. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118705 · Cited by 3
Wang, S., Chou, H.-Y., Liu, P.-H., Su, H.-H., Hung, G., Chou, C., Tseng, L., Shen, Y., Yen, J., Huang, S., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.281 · Cited by 2
Metadata
- Authors
- Ducker, G. S., Ghergurovich, J. M., Mainolfi, N., Suri, V., Jeong, S. K., Hsin-Jung Li, S., Friedman, A., Manfredi, M. G., Gitai, Z., Kim, H., & Rabinowitz, J. D.
- Affiliations
- Princeton University (US)
- Raze Therapeutics, Cambridge, MA 02139;
- Department of Molecular Biology, Princeton University, Princeton NJ 08544;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-10-09
- Volume
- 114
- Issue
- 43
- Pages
- 11404-11409
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5664509
- OpenAlex
- W2761750372
- Cited by
- 261
- References
- 35
- Citations by year
- 2026: 26 · 2025: 29 · 2024: 30 · 2023: 39 · 2022: 29 · 2021: 36 · 2020: 34 · 2019: 26 · 2018: 12
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | NIH | National Cancer Institute (NCI) (R01CA163591, K99CA215307)
- EIF | Stand Up To Cancer (SU2C) (SU2CAACR-DT-20-16)
- American Cancer Society (ACS) (PF-15-190-01-TBE)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- serine hydroxymethyltransferase, folate cycle, one-carbon metabolism, diffuse large B-cell lymphoma, metabolic vulnerability, small molecule inhibitors, cancer metabolism
- MeSH terms
- Animals, Binding Sites, Enzyme Inhibitors, Female, Glycine, Humans, Mice, Nude, Models, Molecular, Neoplasms, Experimental, Protein Conformation, Glycine Hydroxymethyltransferase, Molecular Structure, Gene Expression Regulation, Neoplastic, Lymphoma, Large B-Cell, Diffuse, Gene Deletion, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
